Global safety of over 7 years of etanercept (Enbrel®) therapy in patients with rheumatoid arthritis

被引：0
|
作者：
Moreland, LW
Cohen, SB
Klareskog, L
Baumgartner, SW
Tindall, E
Kalden, J
Whitmore, JB
Tsuji, W
机构：
[1] Univ Alabama, Birmingham, AL USA
[2] Radiant Res, Dallas, TX USA
[3] Karolinska Hosp, S-10401 Stockholm, Sweden
[4] Phys Clin Spokane, Spokane, WA USA
[5] Portland Med Associates, Portland, OR USA
[6] Univ Erlangen Nurnberg, D-8520 Erlangen, Germany
[7] Amgen Inc, Thousand Oaks, CA 91320 USA
来源：
ARTHRITIS AND RHEUMATISM | 2004年 / 50卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：S566 / S566
页数：1
相关论文
共 50 条
  • [1] Safety and efficacy of over 7 years of etanercept therapy in a global population of patients with rheumatoid arthritis
    Lebwohl, M
    Gottlieb, A
    Wallis, W
    Zitnik, R
    [J]. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2005, 52 (03) : P195 - P195
  • [2] Global safety and efficacy of more than 5 years of etanercept (ENBREL®) therapy in rheumatoid arthritis.
    Moreland, LW
    Cohen, SB
    Klareskog, L
    Burge, DJ
    [J]. ARTHRITIS AND RHEUMATISM, 2003, 48 (09): : S125 - S125
  • [3] Global safety and efficacy of more than 5 years of etanercept (ENBREL®) therapy in rheumatoid arthritis.
    Moreland, LW
    Cohen, SB
    Klareskog, L
    Sanda, M
    Wajdula, J
    Burge, DJ
    [J]. ARTHRITIS AND RHEUMATISM, 2002, 46 (09): : S532 - S532
  • [4] Efficacy and safety of over 7 years of etanercept (Enbrel®) therapy in north American patients with early and long-standing rheumatoid arthritis.
    Weinblatt, ME
    Genovese, MC
    Moreland, LW
    Bathon, JM
    Kremer, JM
    Fleischmann, RM
    Schiff, MH
    Whitmore, JB
    White, B
    [J]. ARTHRITIS AND RHEUMATISM, 2004, 50 (09): : S184 - S184
  • [5] Efficacy and safety of over 8 years of etanercept (ENBREL®) therapy in north American patients with early and long-standing rheumatoid arthritis
    Weinblatt, M. E.
    Genovese, M. C.
    Moreland, L. W.
    Bathon, J. M.
    Kremer, J. M.
    Fleischmann, R. M.
    Schiff, M. H.
    Chon, Y.
    Peloso, P.
    White, B.
    Ratnasingham, L.
    [J]. RHEUMATOLOGY, 2006, 45 : I44 - I45
  • [6] Safety of over 8 years of continuous etanercept therapy in patients with juvenile rheumatoid arthritis
    Lovell, D. L.
    Giannini, E. H.
    Wallace, C. A.
    Ilowite, N. T.
    Reiff, A. O.
    Chon, Y.
    Lin, S.
    Baumgarter, S. W.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2007, 66 : 112 - 112
  • [7] Efficacy and safety of over 9 years of etanercept (ENBREL®) therapy in north American patients with early and long-standing rheumatoid arthritis.
    Weinblatt, M. E.
    Genovese, M. C.
    Moreland, L. W.
    Bathon, J. M.
    Kremer, J. M.
    Fleischmann, R. M.
    Schiff, M. H.
    Chon, Y.
    Tsuji, W.
    [J]. ARTHRITIS AND RHEUMATISM, 2006, 54 (09): : S249 - S249
  • [8] Efficacy and safety of over 8 years of etanercept (Enbrel®) therapy in North American patients with early and long-standing rheumatoid arthritis.
    Weinblatt, ME
    Genovese, MC
    Moreland, LW
    Bathon, JM
    Kremer, JM
    Fleischmann, RM
    Schiff, MH
    Xia, HA
    Peloso, P
    White, B
    [J]. ARTHRITIS AND RHEUMATISM, 2005, 52 (09): : S541 - S541
  • [9] Global safety and efficacy of up to five years of etanercept (Enbrel®) therapy.
    Klareskog, L
    Moreland, LM
    Cohen, SB
    Sanda, M
    Burge, DJ
    [J]. ARTHRITIS AND RHEUMATISM, 2001, 44 (09): : S77 - S77
  • [10] Enbrel® (etanercept) pharmacokinetics in patients with rheumatoid arthritis.
    Kremer, JM
    Spencer-Green, GT
    Hanna, RK
    Korth-Bradley, JM
    [J]. ARTHRITIS AND RHEUMATISM, 2000, 43 (09): : S229 - S229
12345